Physician profile

Maria O Lopez

Internal Medicine · Wellington, FL

NPI 1538139936

$4,385.65

in general payments reported to CMS, 2019-2025

36 companies · $147 in 2025

The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$789.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $731.21 2020-2025
Abbott Laboratories $687.01 2019-2022
Lilly USA, LLC $345.62 2019-2025 Zepbound
Novo Nordisk INC $314.11 2019-2020
Astrazeneca Pharmaceuticals LP $260.51 2019-2024 Farxiga
Amgen INC. $240.78 2019-2025 Otezla, Repatha, Evenity
Amarin Pharma, INC. $182.85 2019-2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $151.87 2020-2023 Xifaxan
Harmony Biosciences LLC $132.82 2020
Exact Sciences Corporation $128.59 2023-2024 Cologuard Collection Kit
Evoke Pharma, INC. $122.67 2020-2023 Gimoti
Boehringer Ingelheim Pharmaceuticals, INC. $113.02 2021-2023 Tradjenta, Jardiance
Pfizer INC. $107.12 2019-2023
Janssen Biotech, INC. $89.92 2022-2023 Stelara, Simponi Aria, Remicade
Bayer Healthcare Pharmaceuticals INC. $78.59 2022
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $71.75 2019-2022
Intercept Pharmaceuticals, INC. $62.75 2022-2023 Ocaliva
Idorsia Pharmaceuticals US INC $57.75 2023 Quviviq
Mylan Specialty L.P. $57.24 2019-2021
Redhill Biopharma INC. $53.42 2020-2022
Merck Sharp & Dohme LLC $52.12 2021-2022
Kowa Pharmaceuticals America, INC. $34.70 2019
Eisai INC. $32.90 2020-2021
Ironwood Pharmaceuticals, INC $32.42 2019-2020
Esperion Therapeutics, INC. $30.98 2021
Arbor Pharmaceuticals, INC. $27.59 2019
Shire North American Group INC $26.22 2019
Radius Health, INC. $26.17 2019
Novartis Pharmaceuticals Corporation $22.93 2019
Cardiovascular Systems INC. $18.51 2022
Biohaven Pharmaceutical Holding Company LTD. $18.29 2022
Dermira, INC. $17.02 2020
Astellas Pharma US INC $15.41 2019
Ibsa Pharma INC. $14.68 2019
Glaxosmithkline, LLC. $14.46 2025 Trelegy Ellipta
Allergan, INC. $11.65 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Maria O Lopez

$4,385.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/115131/maria-o-lopez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.